BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

689 related articles for article (PubMed ID: 6707201)

  • 1. Myoadenylate deaminase deficiency. Functional and metabolic abnormalities associated with disruption of the purine nucleotide cycle.
    Sabina RL; Swain JL; Olanow CW; Bradley WG; Fishbein WN; DiMauro S; Holmes EW
    J Clin Invest; 1984 Mar; 73(3):720-30. PubMed ID: 6707201
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Disruption of the purine nucleotide cycle. A potential explanation for muscle dysfunction in myoadenylate deaminase deficiency.
    Sabina RL; Swain JL; Patten BM; Ashizawa T; O'Brien WE; Holmes EW
    J Clin Invest; 1980 Dec; 66(6):1419-23. PubMed ID: 7440723
    [TBL] [Abstract][Full Text] [Related]  

  • 3. AMP deaminase deficiency: study of the human skeletal muscle purine metabolism during ischaemic isometric exercise.
    Sinkeler SP; Binkhorst RA; Joosten EM; Wevers RA; Coerwinkei MM; Oei TL
    Clin Sci (Lond); 1987 Apr; 72(4):475-82. PubMed ID: 3829596
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Skeletal muscle adenosine, inosine and hypoxanthine release following ischaemic forearm exercise in myoadenylate deaminase deficiency and McArdle's disease.
    Sinkeler S; Joosten E; Wevers R; Binkhorst R; Oei L
    Adv Exp Med Biol; 1986; 195 Pt B():517-23. PubMed ID: 3464164
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myoadenylate deaminase deficiency and forearm ischemic exercise testing.
    Valen PA; Nakayama DA; Veum J; Sulaiman AR; Wortmann RL
    Arthritis Rheum; 1987 Jun; 30(6):661-8. PubMed ID: 3606685
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Ischaemic exercise test in myoadenylate deaminase deficiency and McArdle's disease: measurement of plasma adenosine, inosine and hypoxanthine.
    Sinkeler SP; Joosten EM; Wevers RA; Binkhorst RA; Oerlemans FT; van Bennekom CA; Coerwinkel MM; Oei TL
    Clin Sci (Lond); 1986 Apr; 70(4):399-401. PubMed ID: 3457669
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Exercising muscle does not produce hypoxanthine in adenylate deaminase deficiency.
    Patterson VH; Kaiser KK; Brooke MH
    Neurology; 1983 Jun; 33(6):784-6. PubMed ID: 6682523
    [TBL] [Abstract][Full Text] [Related]  

  • 8. ATP breakdown products in human skeletal muscle during prolonged exercise to exhaustion.
    Norman B; Sollevi A; Kaijser L; Jansson E
    Clin Physiol; 1987 Dec; 7(6):503-10. PubMed ID: 3427883
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Characterization of purine nucleotide metabolism in primary rat cardiomyocyte cultures.
    Zoref-Shani E; Kessler-Icekson G; Wasserman L; Sperling O
    Biochim Biophys Acta; 1984 Jun; 804(2):161-8. PubMed ID: 6326848
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Myoadenylate deaminase deficiency: diagnosis by forearm ischemic exercise testing.
    Valen PA; Nakayama DA; Veum JA; Wortmann RL
    Adv Exp Med Biol; 1986; 195 Pt B():525-8. PubMed ID: 3766241
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Muscle adenine nucleotide metabolism during and in recovery from maximal exercise in humans.
    Zhao S; Snow RJ; Stathis CG; Febbraio MA; Carey MF
    J Appl Physiol (1985); 2000 May; 88(5):1513-9. PubMed ID: 10797106
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myoadenylate deaminase deficiency: absence of correlation with exercise intolerance in 452 muscle biopsies.
    Mercelis R; Martin JJ; de Barsy T; Van den Berghe G
    J Neurol; 1987 Aug; 234(6):385-9. PubMed ID: 3655841
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Myoadenylate deaminase deficiency: a new disease of muscle.
    Fishbein WN; Armbrustmacher VW; Griffin JL
    Science; 1978 May; 200(4341):545-8. PubMed ID: 644316
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Myoadenylate deaminase deficiency: successful symptomatic therapy by high dose oral administration of ribose.
    Zöllner N; Reiter S; Gross M; Pongratz D; Reimers CD; Gerbitz K; Paetzke I; Deufel T; Hübner G
    Klin Wochenschr; 1986 Dec; 64(24):1281-90. PubMed ID: 3102830
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The purine nucleotide cycle in skeletal muscle.
    Lowenstein JM; Goodman MN
    Fed Proc; 1978 Jul; 37(9):2308-12. PubMed ID: 658470
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mechanism of ATP catabolism induced by deoxyadenosine and other nucleosides in adenosine deaminase-inhibited human erythrocytes.
    Bontemps F; Van den Berghe G
    Adv Exp Med Biol; 1989; 253B():267-74. PubMed ID: 2558538
    [No Abstract]   [Full Text] [Related]  

  • 17. Influence of sprint training on human skeletal muscle purine nucleotide metabolism.
    Stathis CG; Febbraio MA; Carey MF; Snow RJ
    J Appl Physiol (1985); 1994 Apr; 76(4):1802-9. PubMed ID: 8045862
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Myoadenylate deaminase deficiency: an enzyme defect in search of a disease.
    Joosten E; van Bennekom C; Oerlemans F; De Bruyn C; Oei T; Trijbels J
    Adv Exp Med Biol; 1984; 165 Pt A():85-9. PubMed ID: 6720421
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Extracellular metabolism of adenine nucleotides and adenosine in the innervated skeletal muscle of the frog.
    Cunha RA; Sebastião AM
    Eur J Pharmacol; 1991 May; 197(1):83-92. PubMed ID: 1654262
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Familial myoadenylate deaminase deficiency and exertional myalgia.
    Kelemen J; Rice DR; Bradley WG; Munsat TL; DiMauro S; Hogan EL
    Neurology; 1982 Aug; 32(8):857-63. PubMed ID: 7201581
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 35.